<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01192529</url>
  </required_header>
  <id_info>
    <org_study_id>VEGENAT-SUPR</org_study_id>
    <secondary_id>SUPRESSI2010-PROYECTO CDTI</secondary_id>
    <nct_id>NCT01192529</nct_id>
  </id_info>
  <brief_title>Evaluation of a Diet in Patients With Senile Dementia</brief_title>
  <acronym>SUPRESSI</acronym>
  <official_title>Clinical Evaluation of an Specific Diet for People With Dementia Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vegenat, S.A.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vegenat, S.A.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The most common symptoms associated to senile dementia disease are confusion about schedules,
      hyperactivity... In this sense, these patients have frequently poor nutrition, resulting in
      malnutrition problems or malnutrition high risk.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to assess if the daily intake of a specific nutritional
      supplement versus a non specific supplement one is related to malnutrition or malnutrition
      risk reduction and contributes to an improvement in cognitive and functional parameters in
      patients with senile dementia.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2010</start_date>
  <completion_date type="Anticipated">December 2012</completion_date>
  <primary_completion_date type="Anticipated">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nutritional and cognitive status in elderly people</measure>
    <time_frame>1 year</time_frame>
    <description>The evaluation include: Nutritional evaluation, Improvement of Anthropometric and Biochemical parameters evaluation in relation to patient malnutrition, Patient's cognitive status evaluation (Folstein's MMSE and GDS scale), Functional and psychopathological aspects evaluation (blessed Scale), Global Impresion of Change Evaluation(CIBIC plus Scale), Quality of life evaluation (Short Form 36 questionaire), Memory Evaluation (Rey Auditory Learning Test), Appearance of gastrointestinal events evaluation, Diet and Intake acceptance evaluation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical parameters measure</measure>
    <time_frame>8 months</time_frame>
    <description>Fatty acid profile of plasma and erythrocytes, plasma levels of some proinflammatory cytokines and b-amyloid, genotyped, oxidative stress determination, total proteins determination, total lymphocytes, albumin, pre-albumin, transferrine, Reactive C protein (RCP), homocystein, total cholesterol, plasma level of glucose, Homeostasis Model Assessment and Renal function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">184</enrollment>
  <condition>Alzheimer's Disease</condition>
  <condition>Parkinson's Disease</condition>
  <condition>Senile Dementia</condition>
  <arm_group>
    <arm_group_label>Experimental Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to their daily diet, patients of this group will receive 400 ml per day of &quot;Supressi&quot; nutritional supplement</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In addition to their daily diet, patients of this group will receive 400 ml per day of &quot;T-Diet plus High Protein&quot; product</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Supressi. T-Diet plus Range</intervention_name>
    <description>Supressi is a complete high protein and moderated high energy oral nutrition supplement, indicated for the dietary management of patients with neurodegenerative diseases and related malnutrition.
Experimental group patients will receive, 2 packs per day (Tetra brik aseptic)of 200 ml for 6 months.</description>
    <arm_group_label>Experimental Group</arm_group_label>
    <other_name>VEG001</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>High Protein. T-Diet plus Range</intervention_name>
    <description>T-Diet plus High Protein is a complete high protein and moderated high energy oral nutrition supplement, indicated for the dietary management of patient with related malnutrition and with increased protein requirements.</description>
    <arm_group_label>Control Group</arm_group_label>
    <other_name>VEG002</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 70 years with neurologist or geriatrician dementia diagnosis
             (Alzheimer's disease, Parkinson's or mixed), with mild or moderate cognitive
             impairment degree (Between 24 and 14 MMSE).

          -  Patients with or at malnutrition risk (Mini Nutritional Assessment screening positive)

        Exclusion Criteria:

          -  Patients with decompensated kidney failure, creatine and/or bilirubin greater than 2,
             uric acid higher than 8 mg/dl, and glomerular filtration under 60 ml/minute.

          -  Patients with Diabetes mellitus poorly controlled (Glycemia &gt; 200 mg/dl)

          -  Patients with decompensated hypertension.

          -  Patients with pharmacological treatment or consuming supplements containing specific
             supplementation of experimental product (omega 3 and/or vitamins supplements).

          -  Post-stroke vascular dementias.

          -  Do not achieve any inclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antonio J Pérez de la Cruz, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Nutrition and Dietetic Unit, University Hospital Virgen de las Nieves</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ángel Gil Hernández, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Biochemistry and Molecular Biology II. University of Granada</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Adrián Arés Luque, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neurological Unit, Complejo Asistencial de León</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ángel Gil Hernández, PhD</last_name>
    <phone>+34 695 466 922</phone>
    <email>agil@ugr.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Antonio J Pérez de la Cruz, MD PhD</last_name>
    <phone>+34 639 236 825</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Nutrition and Dietetic Unit, University Hospital Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antonio J Pérez de la Cruz, MD, PhD</last_name>
      <phone>+ 34 639 236 825</phone>
      <email>antonioj.perez.sspa@juntadeandalulcia.es</email>
    </contact>
    <investigator>
      <last_name>Antonio J Pérez de la Cruz, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Biochemistry and Molecular Biology II. University of Granada</name>
      <address>
        <city>Granada</city>
        <zip>18100</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ángel Gil Hernández, PhD</last_name>
      <phone>+34 695 466 922</phone>
      <email>agil@ugr.es</email>
    </contact>
    <investigator>
      <last_name>Ángel Gil Hernández, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Neurological Unit, Complejo Asistencial de León</name>
      <address>
        <city>León</city>
        <zip>24071</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrián Arés Luque, MD</last_name>
      <phone>+34 609 022 840</phone>
      <email>adrianares@telefonica.net</email>
    </contact>
    <investigator>
      <last_name>Adrián Arés Luque, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2010</study_first_submitted>
  <study_first_submitted_qc>August 30, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2010</study_first_posted>
  <last_update_submitted>June 21, 2012</last_update_submitted>
  <last_update_submitted_qc>June 21, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 22, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Senile</keyword>
  <keyword>Dementia</keyword>
  <keyword>Neurodegenerative</keyword>
  <keyword>Supressi</keyword>
  <keyword>Specific diet</keyword>
  <keyword>Cognitive Status</keyword>
  <keyword>Memory</keyword>
  <keyword>Malnutrition</keyword>
  <keyword>Parkinson</keyword>
  <keyword>Alzheimer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phentermine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

